RORACT-1

Product Introduction RORACT-1

Meropenem is a broad-spectrum carbapenem antibiotic. Meropenem is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

Indication of RORACT-1

• Meropenem, a penem group antibiotic that acts via inhibiting growth of disease causing germs. Being a broad spectrum antibiotic it is prescribed in cases of brain infections, skin structure infections, intra-abdominal infections, blood infections and post-surgical infections.
• Complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa,
• Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B.

Side Effects

Common side effects are Hypotension, muscle cramps, headache, nausea, dizziness, Fatigue, Arthralgia, Back pain, hypertension, fluid overload, peripheral edema, cough, vomiting, diarrhea, Constipation and Pruritus.